NCCN Hem Congress 2016 for Android
Use the app to browse the congress agenda, view general session slide presentations, read speaker biographies, and access accreditation, disclosure, and supporter information.
For more than ten years, this annual congress has focused on new approaches incorporated into the treatment of hematologic malignancies, including the use of drugs, biologics, and diagnostics. Led by Co-Chair’s Ranjana H. Advani, MD from Stanford Cancer Institute and Andrew D. Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center, this year’s congress agenda is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
To register for the congress or to learn more about NCCN, please visit NCCN.org/hem.